277 studies found for:    "Pulmonary Emphysema"
Show Display Options
RSS Create an RSS feed from your search for:
"Pulmonary Emphysema"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)
Condition: Pulmonary Emphysema in Alpha-1 PI Deficiency
Interventions: Biological: Alpha1-proteinase inhibitor (human), modified process (Alpha-1 MP);   Other: 0.9% Sodium Chloride for Injection, USP
2 Recruiting Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema
Condition: Pulmonary Emphysema
Interventions: Biological: Mesenchymal stem cells;   Other: Reference therapy: 400 mL of 0.9% NaCl solution
3 Terminated Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR Hydrogel
4 Terminated Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR Hydrogel
5 Active, not recruiting Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.
Conditions: Emphysema;   Alpha 1-proteinase Inhibitor Deficiency
Intervention: Biological: Alpha1- proteinase inhibitor [human]
6 Completed Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor (API) Deficiency
Conditions: Alpha1-proteinase Inhibitor Deficiency;   Emphysema
Interventions: Biological: Alpha1-proteinase inhibitor;   Other: Placebo
7 Recruiting Long Term Follow up Investigation of Endobronchial Valves in Emphysema
Condition: Pulmonary Emphysema
Intervention: Device: Zephyr Endobronchial Valve (EBV)
8 Terminated Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
Condition: Pulmonary Emphysema
Interventions: Device: Treatment plus Optimal Medical Therapy;   Other: Optimal Medical Therapy
9 Completed Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
Conditions: Pulmonary Emphysema;   Chronic Obstructive Pulmonary Disease
Intervention: Drug: Biologic Lung Volume Reduction (BLVR) - 10 mL Hydrogel
10 Completed US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study
Conditions: Pulmonary Emphysema;   Chronic Obstructive Pulmonary Disease
Intervention: Drug: Biologic Lung Volume Reduction (BLVR) - 20 mL Hydrogel
11 Completed US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
Condition: Pulmonary Emphysema
Intervention: Drug: BLVR System
12 Completed US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR Treatment
13 Completed AeriSeal® System for Lung Volume Reduction in Patients With Advanced Emphysema
Conditions: Pulmonary Emphysema;   COPD;   Lung Diseases
Intervention: Device: AeriSeal System
14 Completed US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation
Condition: Pulmonary Emphysema
Intervention: Biological: BLVR
15 Recruiting The Effect and Mechanism of Bronchoscopic Lung Volume Reduction by Endobronchial Valve in Korean Emphysema Patients
Condition: Pulmonary Emphysema
Intervention: Device: Endobronchial valve
16 Unknown  AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation
Conditions: Pulmonary Emphysema;   COPD;   Lung Diseases
Intervention: Device: AeriSeal System
17 Terminated A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema
Conditions: Pulmonary Emphysema;   Chronic Obstructive Pulmonary Disease(COPD);   Lung Diseases
Intervention: Device: AeriSeal System
18 Unknown  Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency
Condition: Hereditary Emphysema (Alpha 1-antitrypsin Deficiency)
Intervention: Device: Implantation of intrabronchial valves (IBV) (Spiration IBV)
19 Completed AeriSeal System for Lung Volume Reduction
Conditions: Emphysema;   Chronic Obstructive Pulmonary Disease (COPD);   Pulmonary Emphysema;   Lung Diseases
Intervention: Device: AeriSeal System
20 Unknown  Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema
Conditions: Alpha 1-Antitrypsin Deficiency;   Emphysema
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years